TY  - JOUR
T1  - TRials by independent expert bodies
AU  - Breimer LH, Mikhailidis DP
Y1  - 2010/12/13
N1  - 10.1001/archinternmed.2010.457
JO  - Archives of Internal Medicine
SP  - 2042
EP  - 2042
VL  - 170
IS  - 22
N2  - 
Studies conducted by pharmaceutical companies for registration purposes are often constrained. An alternative would be to conduct more trials that are viewed as a priority by independent expert bodies but not necessarily by drug companies. These expert bodies could be funded by a small voluntary contribution collected from drug sales.

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2010.457
UR  - http://dx.doi.org/10.1001/archinternmed.2010.457
ER  -